Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 12, 2015, Pages 1490-1503

  Gregson, Aric L ^a   Hoji, Aki ^b   Injean, Patil ^c   Poynter, Steven T ^c   Briones, Claudia ^c   Palchevskiy, Vyacheslav ^c   Sam Weigt, S ^c   Shino, Michael Y ^c   DerHovanessian, Ariss ^c   Sayah, David ^c   Saggar, Rajan ^c   Ross, David ^c   Ardehali, Abbas ^d   Lynch, Joseph P ^c   Belperio, John A ^c  

^a Section of Infectious Diseases   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Division of Pulmonary   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exosome; Lung; Rejection; RNA; Transplantation

Indexed keywords

CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; MESSENGER RNA; RNA;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXOSOME; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MICROARRAY KIT; PRIORITY JOURNAL; RNA EXTRACTION; RNA SEQUENCE; SPIROMETRY; TRANSBRONCHIAL BIOPSY; ULTRACENTRIFUGATION; ACUTE DISEASE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOLOGY; LUNG; MIDDLE AGED; POSTOPERATIVE COMPLICATION; REPRODUCIBILITY; SURGERY;

ACUTE DISEASE; ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOSOMES; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REPRODUCIBILITY OF RESULTS; RNA;

EID: 84951933250     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201503-0558OC     Document Type: Article

References (51)

1. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-13, discussion 13-14.
2. Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He G-W, Yim A. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg 2006;30:846-851.
3. Verleden GM, Raghu G, Meyer KC, Glanville AR, Corris P. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014;33:127-133.
4. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007;26:681-686.
5. Gelman AE, Li W, Richardson SB, Zinselmeyer BH, Lai J, Okazaki M, Kornfeld CG, Kreisel FH, Sugimoto S, Tietjens JR, et al. Cutting edge: acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009;182:3969-3973.
6. Snell GI, Westall GP, Paraskeva MA. Immunosuppression and allograft rejection following lung transplantation: evidence to date. Drugs 2013; 73:1793-1813.
7. Greenland JR, Jewell NP, Gottschall M, Trivedi NN, Kukreja J, Hays SR, Singer JP, Golden JA, Caughey GH. Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection. Am J Transplant 2014;14:831-840.
8. Glanville AR. The role of surveillance bronchoscopy post-lung transplantation. Semin Respir Crit Care Med 2013;34:414-420.
9. Valadi H, Ekströ m K, Bossios A, Sjö strand M, Lee JJ, Lö tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9: 654-659.
10. Levänen B, Bhakta NR, Torregrosa Paredes P, Barbeau R, Hiltbrunner S, Pollack JL, Skö ld CM, Svartengren M, Grunewald J, Gabrielsson S, et al. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J Allergy Clin Immunol 2013;131:894-903.e8.
11. Bhatnagar S, Schorey JS. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem 2007;282:25779-25789.
12. Kesimer M, Scull M, Brighton B, DeMaria G, Burns K, O'Neal W, Pickles RJ, Sheehan JK. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J 2009;23:1858-1868.
13. Timár CI, Lorincz AM, Csé pá nyi-Kömi R, Vályi-Nagy A, Nagy G, Buzá s EI, Ivá nyi Z, Kittel A, Powell DW, McLeish KR, et al. Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood 2013;121:510-518.
14. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 2005;113:752-760.
15. Gregson AL, Hoji A, Palchevskiy V, Hu S, Weigt SS, Liao E, Derhovanessian A, Saggar R, Song S, Elashoff R, et al. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR71 CD45RA-T regulatory cells. PLoS One 2010;5:e11354.
16. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006;Chapter 3:Unit 3.22.
17. Rubinstein E, Le Naour F, Lagaudriè re-Gesbert C, Billard M, Conjeaud H, Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996;26:2657-2665.
18. Lä sser C, Eldh M, Lö tvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012;59:e3037.
19. R Development Core Team. R: a language and environment for statistical computing [2009; accessed 2015 Nov 13]. Available from: http://www.R-project.org
20. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
21. Krä mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 2014;30:523-530.
22. Liao Y, Smyth GK, Shi W; Y L. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res 2013; 41:e108.
23. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and computational biology solutions using R and bioconductor. New York: Springer; 2005. pp. 397-420.
24. Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 2009;10:161.
25. Hou JC, Min L, Pessin JE. Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm 2009;80:473-506.
26. Ramsköld D, Wang ET, Burge CB, Sandberg R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLOS Comput Biol 2009;5:e1000598.
27. Mü ller H, End C, Weiss C, Renner M, Bhandiwad A, Helmke BM, Gassler N, Hafner M, Poustka A, Mollenhauer J, et al. Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection. Clin Exp Immunol 2008;151:123-129.
28. Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, Kliem A, Reid KB, Poustka A, Skjodt K. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA 1999;96:10794-10799.
29. Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Fö lsch UR, Helmke B, et al. Regulation of dMBT1 via nOD2 and tLR4 in intestinal epithelial cells modulates bacterial recognition and invasion. J Immunol 2007;178:8203-8211.
30. Rundegren J, Arnold RR. Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect Immun 1987;55:288-292.
31. Tino MJ, Wright JR. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. Am J Respir Cell Mol Biol 1999;20:759-768.
32. Mü ller H, Hu J, Popp R, Schmidt MHH, Mü ller-Decker K, Mollenhauer J, Fisslthaler B, Eble JA, Fleming I. Deleted in malignant brain tumors 1 is present in the vascular extracellular matrix and promotes angiogenesis. Arterioscler Thromb Vasc Biol 2012;32:442-448.
33. Liu K-X, Chen S-Q, Zhang H, Guo JY, Li Y-S, Huang W-Q. Intestinal ischaemia/reperfusion upregulates beta-defensin-2 expression and causes acute lung injury in the rat. Injury 2009;40:950-955.
34. Ross DJ, Cole AM, Yoshioka D, Park AK, Belperio JA, Laks H, Strieter RM, Lynch JP III, Kubak B, Ardehali A, et al. Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 78:1222-1224.
35. McDaniel DO, Zhou X, Moore CK, Aru G. Cardiac allograft rejection correlates with increased expressions of Toll-like receptors 2 and 4 and allograft inflammatory factor 1. Transplant Proc 2010;42: 4235-4237.
36. Hoffmann U, Bergler T, Rihm M, Pace C, Krü ger B, Jung B, Reinhold SW, Farkas S, Rü mmele P, Krä mer BK, et al. Impact of Toll-like receptor 2 expression in renal allograft rejection. Nephrol Dial Transplant 2011;26:1080-1087.
37. Deng J-F, Geng L, Qian Y-G, Li H, Wang Y, Xie H-Y, Feng X-W, Zheng S-S. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transplant Proc 2007;39:3222-3224.
38. O Farrell F, Rusten TE, Stenmark H. Phosphoinositide 3-kinases as accelerators and brakes of autophagy. FEBS J 2013;280:6322-6337.
39. Gregson AL, Wang X, Weigt SS, Palchevskiy V, Lynch JP III, Ross DJ, Kubak BM, Saggar R, Fishbein MC, Ardehali A, et al. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med 2013;187:518-526.
40. Weigt SS, Copeland CAF, Derhovanessian A, Shino MY, Davis WA, Snyder LD, Gregson AL, Saggar R, Lynch JP III, Ross DJ, et al. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. Am J Transplant 2013;13:919-927.
41. Gregson AL, Wang X, Injean P, Weigt SS, Shino M, Sayah D, DerHovanessian A, Lynch JP III, Ross DJ, Saggar R, et al. Staphylococcus via an interaction with the ELR1 CXC chemokine ENA-78 is associated with BOS. Am J Transplant 2015;15:792-799.
42. Eskandary F, Bond G, Schwaiger E, Kikic Z, Winzer C, Wahrmann M, Marinova L, Haslacher H, Regele H, Oberbauer R, et al. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Trials 2014; 15:107.
43. Herrera AF, Kim HT, Bindra B, Jones KT, Alyea EP III, Armand P, Cutler CS, Ho VT, Nikiforow S, Blazar BR, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2014;20:1737-1743.
44. Pai C-CS, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, et al. Treatment of chronic graft-versus-host disease with bortezomib. Blood 2014;124: 1677-1688.
45. Tiriveedhi V, Upadhya GA, Busch RA, Gunter KL, Dines JN, Knolhoff BL, Jia J, Sarma NJ, Ramachandran S, Anderson CD, et al. Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression. Transpl Immunol 2014;30:93-98.
46. Li Y, Xie J, Xu X, Wang J, Ao F, Wan Y, Zhu Y. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-l1.l Protein Cell 2013;4:130-141.
47. Xie T, Liang J, Guo R, Liu N, Noble PW, Jiang D. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 2011;43:479-487.
48. Neujahr DC, Uppal K, Force SD, Fernandez F, Lawrence C, Pickens A, Bag R, Lockard C, Kirk AD, Tran V, et al. Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation. Am J Transplant 2014;14:841-848.
49. Hodge G, Hodge S, Reynolds PN, Holmes M. Airway infection in stable lung transplant patients is associated with decreased intracellular T-helper type 1 pro-inflammatory cytokines in bronchoalveolar lavage T-cell subsets. Transpl Infect Dis 2008;10:99-105.
50. Gregson AL, Hoji A, Saggar R, Ross DJ, Kubak BM, Jamieson BD, Weigt SS, Lynch JP III, Ardehali A, Belperio JA, et al. Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation 2008;85:1056-1059.
51. Neujahr DC, Cardona AC, Ulukpo O, Rigby M, Pelaez A, Ramirez A, Gal AA, Force SD, Lawrence EC, Kirk AD, et al. Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 2009;88:521-527.